• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在开放式微流控平台中整合血管表型和蛋白质组学分析。

Integrating Vascular Phenotypic and Proteomic Analysis in an Open Microfluidic Platform.

机构信息

Department of Mechanical Engineering, Seoul National University, Seoul 08826, Republic of Korea.

Interdisciplinary Program in Bioengineering, Seoul National University, Seoul 08826, Republic of Korea.

出版信息

ACS Nano. 2024 Sep 10;18(36):24909-24928. doi: 10.1021/acsnano.4c05537. Epub 2024 Aug 29.

DOI:10.1021/acsnano.4c05537
PMID:39208278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394367/
Abstract

This research introduces a vascular phenotypic and proteomic analysis (VPT) platform designed to perform high-throughput experiments on vascular development. The VPT platform utilizes an open-channel configuration that facilitates angiogenesis by precise alignment of endothelial cells, allowing for a 3D morphological examination and protein analysis. We study the effects of antiangiogenic agents─bevacizumab, ramucirumab, cabozantinib, regorafenib, wortmannin, chloroquine, and paclitaxel─on cytoskeletal integrity and angiogenic sprouting, observing an approximately 50% reduction in sprouting at higher drug concentrations. Precise LC-MS/MS analyses reveal global protein expression changes in response to four of these drugs, providing insights into the signaling pathways related to the cell cycle, cytoskeleton, cellular senescence, and angiogenesis. Our findings emphasize the intricate relationship between cytoskeletal alterations and angiogenic responses, underlining the significance of integrating morphological and proteomic data for a comprehensive understanding of angiogenesis. The VPT platform not only advances our understanding of drug impacts on vascular biology but also offers a versatile tool for analyzing proteome and morphological features across various models beyond blood vessels.

摘要

本研究介绍了一种血管表型和蛋白质组学分析(VPT)平台,旨在对血管发育进行高通量实验。VPT 平台采用开放式通道配置,通过精确对准内皮细胞促进血管生成,从而实现 3D 形态检查和蛋白质分析。我们研究了抗血管生成剂——贝伐单抗、雷莫芦单抗、卡博替尼、瑞戈非尼、渥曼青霉素、氯喹和紫杉醇——对细胞骨架完整性和血管生成发芽的影响,在较高药物浓度下观察到发芽减少约 50%。精确的 LC-MS/MS 分析揭示了这四种药物对整体蛋白质表达的影响,为与细胞周期、细胞骨架、细胞衰老和血管生成相关的信号通路提供了深入了解。我们的研究结果强调了细胞骨架改变与血管生成反应之间的复杂关系,突出了整合形态和蛋白质组学数据以全面了解血管生成的重要性。VPT 平台不仅推进了我们对药物对血管生物学影响的理解,还为分析除血管以外的各种模型的蛋白质组和形态特征提供了一种多功能工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/2dd9f45b7c3f/nn4c05537_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/daca94154a70/nn4c05537_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/b819c0db9f01/nn4c05537_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/21053b488bff/nn4c05537_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/bd4f8870a663/nn4c05537_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/4600af27756e/nn4c05537_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/5cd943f91e52/nn4c05537_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/2dd9f45b7c3f/nn4c05537_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/daca94154a70/nn4c05537_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/b819c0db9f01/nn4c05537_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/21053b488bff/nn4c05537_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/bd4f8870a663/nn4c05537_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/4600af27756e/nn4c05537_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/5cd943f91e52/nn4c05537_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/11394367/2dd9f45b7c3f/nn4c05537_0007.jpg

相似文献

1
Integrating Vascular Phenotypic and Proteomic Analysis in an Open Microfluidic Platform.在开放式微流控平台中整合血管表型和蛋白质组学分析。
ACS Nano. 2024 Sep 10;18(36):24909-24928. doi: 10.1021/acsnano.4c05537. Epub 2024 Aug 29.
2
Anchor-IMPACT: A standardized microfluidic platform for high-throughput antiangiogenic drug screening.锚定-IMPACT:一种用于高通量抗血管生成药物筛选的标准化微流控平台。
Biotechnol Bioeng. 2021 Jul;118(7):2524-2535. doi: 10.1002/bit.27765. Epub 2021 Apr 8.
3
A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs.基于体外人血管模型的血管内皮生长因子依赖性发芽血管生成分析法用于抗血管生成药物的研究。
EBioMedicine. 2018 Jan;27:225-236. doi: 10.1016/j.ebiom.2017.12.014. Epub 2017 Dec 20.
4
Human Ocular Angiogenesis-Inspired Vascular Models on an Injection-Molded Microfluidic Chip.注塑微流控芯片上受人类眼部血管生成启发的血管模型。
Adv Healthc Mater. 2019 Aug;8(15):e1900328. doi: 10.1002/adhm.201900328. Epub 2019 Jun 14.
5
Perfused 3D angiogenic sprouting in a high-throughput in vitro platform.高通量体外平台中灌注的 3D 血管生成发芽
Angiogenesis. 2019 Feb;22(1):157-165. doi: 10.1007/s10456-018-9647-0. Epub 2018 Aug 31.
6
Robust and Scalable Angiogenesis Assay of Perfused 3D Human iPSC-Derived Endothelium for Anti-Angiogenic Drug Screening.用于抗血管生成药物筛选的灌注 3D 人 iPSC 衍生内皮细胞的稳健和可扩展的血管生成分析。
Int J Mol Sci. 2020 Jul 7;21(13):4804. doi: 10.3390/ijms21134804.
7
Physicochemical regulation of endothelial sprouting in a 3D microfluidic angiogenesis model.三维微流控血管生成模型中内皮芽生的物理化学调控。
J Biomed Mater Res A. 2013 Oct;101(10):2948-56. doi: 10.1002/jbm.a.34587. Epub 2013 Apr 5.
8
A Bivalent Role of Genistein in Sprouting Angiogenesis.染料木黄酮在血管生成发芽中的双重作用。
Planta Med. 2018 Jul;84(9-10):653-661. doi: 10.1055/a-0587-5991. Epub 2018 Mar 14.
9
Ethyl Acetate Fraction of Teucrium Polium Extract Abolishes Human Umbilical Vein Endothelial Cells (HUVEC) Tubulogenesis in Collagen Bed through Suppression of Cell Proliferation/VEGF Secretion.百里香叶石蚕提取物的乙酸乙酯部分通过抑制细胞增殖/血管内皮生长因子分泌,消除了人脐静脉内皮细胞(HUVEC)在胶原床中的管状形成。
Iran J Allergy Asthma Immunol. 2019 Jun 8;18(3):281-288. doi: 10.18502/ijaai.v18i3.1121.
10
Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.从 Tylophora indica 中分离得到的 phenanthraindolizidine 生物碱 tylophorine 通过靶向血管内皮生长因子受体 2 介导的血管生成发挥抗血管生成和抗肿瘤活性。
Mol Cancer. 2013 Jul 29;12:82. doi: 10.1186/1476-4598-12-82.

本文引用的文献

1
Angio-Net: deep learning-based label-free detection and morphometric analysis of angiogenesis.血管网络(Angio-Net):基于深度学习的无标记血管生成检测与形态计量分析
Lab Chip. 2024 Feb 13;24(4):751-763. doi: 10.1039/d3lc00935a.
2
Angiogenesis-on-a-chip coupled with single-cell RNA sequencing reveals spatially differential activations of autophagy along angiogenic sprouts.血管生成芯片与单细胞 RNA 测序相结合揭示了沿着血管生成芽的自噬的空间差异激活。
Nat Commun. 2024 Jan 3;15(1):230. doi: 10.1038/s41467-023-44427-0.
3
Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy.
靶向线粒体伴侣蛋白 TRAP1 可减轻缺血性视网膜病变中的血管病变。
Adv Sci (Weinh). 2024 Jan;11(2):e2302776. doi: 10.1002/advs.202302776. Epub 2023 Nov 20.
4
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's Disease.转录因子EB(TFEB)在阿尔茨海默病和帕金森病中功能的新见解。
Aging Dis. 2023 Jun 1;14(3):652-669. doi: 10.14336/AD.2022.0927.
5
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.血管生成信号通路与癌症的抗血管生成治疗。
Signal Transduct Target Ther. 2023 May 11;8(1):198. doi: 10.1038/s41392-023-01460-1.
6
SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space.SproutAngio:一种开源的生物影像信息学工具,用于对发芽血管生成和管腔空间进行定量分析。
Sci Rep. 2023 May 4;13(1):7279. doi: 10.1038/s41598-023-33090-6.
7
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies.内皮抑素与癌症治疗:抗血管内皮生长因子单克隆抗体的一种新型潜在替代方案
Biomedicines. 2023 Feb 27;11(3):718. doi: 10.3390/biomedicines11030718.
8
Extracellular Matrix-Derived Biophysical Cues Mediate Interstitial Flow-Induced Sprouting Angiogenesis.细胞外基质衍生的生物物理线索介导间质液流动诱导的血管生成。
ACS Appl Mater Interfaces. 2023 Mar 29;15(12):15047-15058. doi: 10.1021/acsami.2c15180. Epub 2023 Mar 14.
9
Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer.regorafenib 治疗进展期不可切除转移性结直肠癌的 II 期剂量滴定研究。
Sci Rep. 2023 Feb 9;13(1):2331. doi: 10.1038/s41598-022-24057-0.
10
The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy.VEGF/VEGFR 轴再探:对癌症治疗的影响。
Int J Mol Sci. 2022 Dec 9;23(24):15585. doi: 10.3390/ijms232415585.